Intratympanic dexamethasone in Meniere’s disease
Conclusion: Intratympanic dexamethasone for Meniere’s disease is very satisfactory if medical treatment fails with good vertigo control and no risk to hearing.
Source: Egyptian Journal of Ear, Nose, Throat and Allied Sciences - Category: ENT & OMF Source Type: research
More News: Dexamethasone | ENT & OMF | Hospital Management | Men | Meniere's Disease | Middle East Health | Statistics | Study | Tinnitus | Vertigo